【藥品性質提示】
根據 2019 AGS Beers Criteria,本藥品為【潛在不適當用藥 (PIM)】,不建議用於老年人 (除非用於胃輕癱,且建議療程不超過12周)。
|
促進蠕動 Symptomatic treatment of diabetic gastroparesis; gastroesophageal reflux; prevention and/or treatment of nausea and vomiting associated with chemotherapy, or postsurgery